» Articles » PMID: 31462092

2018 George Lyman Duff Memorial Lecture: Genetics and Genomics of Coronary Artery Disease: A Decade of Progress

Overview
Date 2019 Aug 30
PMID 31462092
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have led to a broader understanding of the genetic architecture of coronary artery disease and demonstrate that it largely derives from the cumulative effect of multiple common risk alleles individually of small effect size rather than rare variants with large effects on coronary artery disease risk. The tools applied include genome-wide association studies encompassing over 200 000 individuals complemented by bioinformatic approaches including imputation from whole-genome data sets, expression quantitative trait loci analyses, and interrogation of ENCODE (Encyclopedia of DNA Elements), Roadmap Epigenetic Project, and other data sets. Over 160 genome-wide significant loci associated with coronary artery disease risk have been identified using the genome-wide association studies approach, 90% of which are situated in intergenic regions. Here, I will describe, in part, our research over the last decade performed in collaboration with a series of bright trainees and an extensive number of groups and individuals around the world as it applies to our understanding of the genetic basis of this complex disease. These studies include computational approaches to better understand missing heritability and identify causal pathways, experimental approaches, and progress in understanding at the molecular level the function of the multiple risk loci identified and potential applications of these genomic data in clinical medicine and drug discovery.

Citing Articles

Pharmacogenomics-based systematic review of coronary artery disease based on personalized medicine procedure.

Kazemi Asl S, Rahimzadegan M, Kazemi Asl A Heliyon. 2024; 10(7):e28983.

PMID: 38601677 PMC: 11004819. DOI: 10.1016/j.heliyon.2024.e28983.


Polygenic Risk Scores in Predicting Coronary Artery Disease in Symptomatic Patients. A Validation Study.

Kujala I, Vangipurapu J, Maaniitty T, Saraste A, Kere J, Knuuti J J Atheroscler Thromb. 2024; 31(7):1058-1071.

PMID: 38403640 PMC: 11224689. DOI: 10.5551/jat.64623.


Coronary artery disease risk factors affected by RNA modification-related genetic variants.

Li R, Zhang H, Tang F, Duan C, Liu D, Wu N Front Cardiovasc Med. 2022; 9:985121.

PMID: 36204584 PMC: 9530202. DOI: 10.3389/fcvm.2022.985121.

References
1.
Sarwar N, Sandhu M, Ricketts S, Butterworth A, Di Angelantonio E, Boekholdt S . Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010; 375(9726):1634-9. PMC: 2867029. DOI: 10.1016/S0140-6736(10)60545-4. View

2.
Dandona S, Stewart A, Chen L, Williams K, So D, OBrien E . Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol. 2010; 56(6):479-86. DOI: 10.1016/j.jacc.2009.10.092. View

3.
Helgadottir A, Thorleifsson G, Magnusson K, Gretarsdottir S, Steinthorsdottir V, Manolescu A . The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008; 40(2):217-24. DOI: 10.1038/ng.72. View

4.
Casas J, Ninio E, Panayiotou A, Palmen J, Cooper J, Ricketts S . PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry. Circulation. 2010; 121(21):2284-93. PMC: 3377948. DOI: 10.1161/CIRCULATIONAHA.109.923383. View

5.
McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox D . A common allele on chromosome 9 associated with coronary heart disease. Science. 2007; 316(5830):1488-91. PMC: 2711874. DOI: 10.1126/science.1142447. View